Wird geladen...

Proposal for a Novel Methodology to Screen And Score Cost Versus Survival for Anticancer Drugs in Metastatic Disease: Could Cost Weigh in Evaluation?

PURPOSE: Rising costs of anticancer drugs prompt concerns about their approval, use, and affordability. A methodology was developed to evaluate cost versus survival for anticancer drugs in metastatic breast cancer and non–small-cell lung cancer (NSCLC). METHODS: Costs of evaluated drugs were calcula...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Guirgis, Helmy M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2012
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3396818/
https://ncbi.nlm.nih.gov/pubmed/23180986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2011.000390
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!